chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021 at 6:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with VALACYCLOVIR [VALACICLOVIR] in April 2021 for Shingles, at a dose of 1 gram. At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  The patient went to the clinic and was prescribed valacyclovir for shingles.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Swelling
Clinical narrative: Swelling in her neck which doubled in size in 1 week and it was decreasing in size till she received the 2nd dose never went away; Nausea; Mild headache; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling in her neck which doubled in size in 1 week and it was decreasing in size till she received the 2nd dose never went away), NAUSEA (Nausea) and HEADACHE (Mild headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011AZ1A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROXYCHLOROQUINE, METFORMIN, ASPIRIN [ACETYLSALICYLIC ACID] and DEXLANSOPRAZOLE (DEXILANT) for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced NAUSEA (Nausea) and HEADACHE (Mild headache). On 16-Mar-2021, the patient experienced SWELLING (Swelling in her neck which doubled in size in 1 week and it was decreasing in size till she received the 2nd dose never went away). On 14-Mar-2021, NAUSEA (Nausea) and HEADACHE (Mild headache) had resolved. At the time of the report, SWELLING (Swelling in her neck which doubled in size in 1 week and it was decreasing in size till she received the 2nd dose never went away) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment medications were unknown.   This case was linked to MOD-2021-076316 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow-up information received on 06-MAY-2021 contains non-significant information: Additional information received included information regarding consultation with the physician for the swelling.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.    Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow-up information received on 06-MAY-2021 contains significant information: Reporter contact details was updated. Vaccine route of administration was updated.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea
Clinical narrative: Chest was heavy; Making it difficult to breath; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest was heavy) and DYSPNOEA (Making it difficult to breath) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced CHEST DISCOMFORT (Chest was heavy) and DYSPNOEA (Making it difficult to breath). At the time of the report, CHEST DISCOMFORT (Chest was heavy) and DYSPNOEA (Making it difficult to breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional product use issue, Palpitations
Clinical narrative: Patient did not get 2nd dose on monday 12Apr2021; Had a fast heart beat that lasted; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Had a fast heart beat that lasted) and INTENTIONAL PRODUCT USE ISSUE (Patient did not get 2nd dose on monday 12Apr2021) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PALPITATIONS (Had a fast heart beat that lasted). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Patient did not get 2nd dose on monday 12Apr2021). At the time of the report, PALPITATIONS (Had a fast heart beat that lasted) had not resolved and INTENTIONAL PRODUCT USE ISSUE (Patient did not get 2nd dose on monday 12Apr2021) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No concomitant medication was provided.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Hypokinesia, Movement disorder
Clinical narrative: His left arm "was hanging" just like he had a Stroke; He cannot raise it up and cannot make a fist but he can move his fingers; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (His left arm "was hanging" just like he had a Stroke) and HYPOKINESIA (He cannot raise it up and cannot make a fist but he can move his fingers) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced MOVEMENT DISORDER (His left arm "was hanging" just like he had a Stroke) and HYPOKINESIA (He cannot raise it up and cannot make a fist but he can move his fingers). At the time of the report, MOVEMENT DISORDER (His left arm "was hanging" just like he had a Stroke) and HYPOKINESIA (He cannot raise it up and cannot make a fist but he can move his fingers) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported.  Treatment information not provided.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, Headache, Pyrexia, Vaccination site pain
Clinical narrative: Loss of smell; Severe Headache; Fever; Pain at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Loss of smell), HEADACHE (Severe Headache), PYREXIA (Fever) and VACCINATION SITE PAIN (Pain at the site of injection) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced HEADACHE (Severe Headache), PYREXIA (Fever) and VACCINATION SITE PAIN (Pain at the site of injection). On 13-Apr-2021, the patient experienced ANOSMIA (Loss of smell). At the time of the report, ANOSMIA (Loss of smell), HEADACHE (Severe Headache), PYREXIA (Fever) and VACCINATION SITE PAIN (Pain at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        relevant concomitant products usage were not reported by the reporter. Treatment details not included.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Nausea
Clinical narrative: Minor limp node swelling; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Minor limp node swelling) and NAUSEA (Nausea) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Minor limp node swelling) and NAUSEA (Nausea). At the time of the report, LYMPHADENOPATHY (Minor limp node swelling) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Vaccinated right arm felt sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Vaccinated right arm felt sore) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031120A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Vaccinated right arm felt sore). At the time of the report, PAIN IN EXTREMITY (Vaccinated right arm felt sore) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-076305 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itching at the injection; Rash that is growing in size at the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection) and VACCINATION SITE RASH (Rash that is growing in size at the injection) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection) and VACCINATION SITE RASH (Rash that is growing in size at the injection). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection) and VACCINATION SITE RASH (Rash that is growing in size at the injection) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Feeling cold, Pain, Pain in extremity
Clinical narrative: Coughing lot; Pain on vaccination arm; Feels cold; Pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing lot), PAIN IN EXTREMITY (Pain on vaccination arm), FEELING COLD (Feels cold), PAIN (Pain) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced COUGH (Coughing lot), PAIN IN EXTREMITY (Pain on vaccination arm), FEELING COLD (Feels cold), PAIN (Pain) and CHILLS (Chills). At the time of the report, COUGH (Coughing lot), PAIN IN EXTREMITY (Pain on vaccination arm), FEELING COLD (Feels cold), PAIN (Pain) and CHILLS (Chills) outcome was unknown.            No relevant concomitant medications were provided.  No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash pruritic, Urticaria
Clinical narrative: Rash spread on part of her torso/ rash spread around neck/ rash on her arm/slightly itchy; Hives all over body; slightly itchy; Rash on her arm, rash spread around neck, rash spread on part of her torso; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rash spread on part of her torso/ rash spread around neck/ rash on her arm/slightly itchy), URTICARIA (Hives all over body), PRURITUS (slightly itchy) and RASH (Rash on her arm, rash spread around neck, rash spread on part of her torso) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included Hives (other things). Concurrent medical conditions included Pulmonary hypertension since 01-Jan-2017. Concomitant products included ESTROGENS CONJUGATED (PREMARIN) from 15-Mar-2001 to an unknown date for Hysterectomy, METOPROLOL, SIMVASTATIN, DOXYCYCLINE and IPRATROPIUM for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced RASH PRURITIC (Rash spread on part of her torso/ rash spread around neck/ rash on her arm/slightly itchy), URTICARIA (Hives all over body), PRURITUS (slightly itchy) and RASH (Rash on her arm, rash spread around neck, rash spread on part of her torso). On 06-Apr-2021, RASH PRURITIC (Rash spread on part of her torso/ rash spread around neck/ rash on her arm/slightly itchy) had resolved, PRURITUS (slightly itchy) and RASH (Rash on her arm, rash spread around neck, rash spread on part of her torso) outcome was unknown. At the time of the report, URTICARIA (Hives all over body) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information was provided.   This case was linked to MOD-2021-255727.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Significant follow up appended
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lethargy, Rhinorrhoea
Clinical narrative: Flu-like symptoms; Lethargic; Sniffles; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), LETHARGY (Lethargic) and RHINORRHOEA (Sniffles) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lupus syndrome (Lupus) and Depression. Concomitant products included HYDROXYCHLOROQUINE for Lupus erythematosus.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), LETHARGY (Lethargic) and RHINORRHOEA (Sniffles). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), LETHARGY (Lethargic) and RHINORRHOEA (Sniffles) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: Hard to lift left arm; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hard to lift left arm) and INJECTION SITE PAIN (Injection site pain) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045AZIA) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PAIN IN EXTREMITY (Hard to lift left arm) and INJECTION SITE PAIN (Injection site pain). At the time of the report, PAIN IN EXTREMITY (Hard to lift left arm) and INJECTION SITE PAIN (Injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Injection site swelling, Pyrexia
Clinical narrative: fever; swelling at the injection site; tired; light continued pain in left leg between knee cap, described as ache; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), FATIGUE (tired) and ARTHRALGIA (light continued pain in left leg between knee cap, described as ache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B28) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), FATIGUE (tired) and ARTHRALGIA (light continued pain in left leg between knee cap, described as ache). At the time of the report, PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), FATIGUE (tired) and ARTHRALGIA (light continued pain in left leg between knee cap, described as ache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use included unspecified eye drops. The patient was treated with Tylenol (paracetamol) and vitamin d 50,000. The reporter did not provide an assessment for the event (s), PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), FATIGUE (tired) and ARTHRALGIA (light continued pain in left leg between knee cap, described as ache).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Complex regional pain syndrome
Clinical narrative: CRPS (Complex Region Pain Syndrome) flare up; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COMPLEX REGIONAL PAIN SYNDROME (CRPS (Complex Region Pain Syndrome) flare up) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included GABAPENTIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), TOPIRAMATE, HYDROXYZINE, LISINOPRIL, METHOCARBAMOL and TIZANIDINE HYDROCHLORIDE (ZANAFLEX) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced COMPLEX REGIONAL PAIN SYNDROME (CRPS (Complex Region Pain Syndrome) flare up). At the time of the report, COMPLEX REGIONAL PAIN SYNDROME (CRPS (Complex Region Pain Syndrome) flare up) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included unspecified oral steroids.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Blood pressure measurement, Headache, Influenza like illness, Malaise
Clinical narrative: stomach feels bad; doesn't feel well; feels like she has the flu; headache; sore arm where she got the injection; throwing up; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach feels bad), MALAISE (doesn't feel well), INFLUENZA LIKE ILLNESS (feels like she has the flu), HEADACHE (headache) and VACCINATION SITE PAIN (sore arm where she got the injection) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020V21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure. Concomitant products included DILTIAZEM for Blood pressure high.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach feels bad), MALAISE (doesn't feel well), INFLUENZA LIKE ILLNESS (feels like she has the flu), HEADACHE (headache), VACCINATION SITE PAIN (sore arm where she got the injection), VOMITING (throwing up) and NAUSEA (nausea). At the time of the report, ABDOMINAL DISCOMFORT (stomach feels bad), MALAISE (doesn't feel well), VACCINATION SITE PAIN (sore arm where she got the injection), VOMITING (throwing up) and NAUSEA (nausea) was resolving and INFLUENZA LIKE ILLNESS (feels like she has the flu) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Blood pressure measurement: unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was able to take her blood pressure medication. The patient was taking Zofran and Compazine for the nausea.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain, Vomiting
Clinical narrative: stomach feels bad; doesn't feel well; feels like she has the flu; headache; sore arm where she got the injection; throwing up; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach feels bad), MALAISE (doesn't feel well), INFLUENZA LIKE ILLNESS (feels like she has the flu), HEADACHE (headache) and VACCINATION SITE PAIN (sore arm where she got the injection) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020V21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure. Concomitant products included DILTIAZEM for Blood pressure high.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach feels bad), MALAISE (doesn't feel well), INFLUENZA LIKE ILLNESS (feels like she has the flu), HEADACHE (headache), VACCINATION SITE PAIN (sore arm where she got the injection), VOMITING (throwing up) and NAUSEA (nausea). At the time of the report, ABDOMINAL DISCOMFORT (stomach feels bad), MALAISE (doesn't feel well), VACCINATION SITE PAIN (sore arm where she got the injection), VOMITING (throwing up) and NAUSEA (nausea) was resolving and INFLUENZA LIKE ILLNESS (feels like she has the flu) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Blood pressure measurement: unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was able to take her blood pressure medication. The patient was taking Zofran and Compazine for the nausea.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Headache, Injection site pain
Clinical narrative: legs became painful; right wrist hurt; swollen lymph node right side of my Armpit; could not lift my right arm above my head; Fever; Chills; Achy; headache; injection site right arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (could not lift my right arm above my head), PAIN IN EXTREMITY (legs became painful), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Achy) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (could not lift my right arm above my head), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Achy), HEADACHE (headache) and INJECTION SITE PAIN (injection site right arm hurt). On an unknown date, the patient experienced PAIN IN EXTREMITY (legs became painful), ARTHRALGIA (right wrist hurt) and LYMPHADENOPATHY (swollen lymph node right side of my Armpit). At the time of the report, PAIN (could not lift my right arm above my head), PAIN IN EXTREMITY (legs became painful), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Achy), HEADACHE (headache), INJECTION SITE PAIN (injection site right arm hurt), ARTHRALGIA (right wrist hurt) and LYMPHADENOPATHY (swollen lymph node right side of my Armpit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 99.3 (abnormal) 99.3.         Concomitant medication was not provided.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Pain, Pain in extremity, Pyrexia
Clinical narrative: legs became painful; right wrist hurt; swollen lymph node right side of my Armpit; could not lift my right arm above my head; Fever; Chills; Achy; headache; injection site right arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (could not lift my right arm above my head), PAIN IN EXTREMITY (legs became painful), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Achy) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (could not lift my right arm above my head), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Achy), HEADACHE (headache) and INJECTION SITE PAIN (injection site right arm hurt). On an unknown date, the patient experienced PAIN IN EXTREMITY (legs became painful), ARTHRALGIA (right wrist hurt) and LYMPHADENOPATHY (swollen lymph node right side of my Armpit). At the time of the report, PAIN (could not lift my right arm above my head), PAIN IN EXTREMITY (legs became painful), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Achy), HEADACHE (headache), INJECTION SITE PAIN (injection site right arm hurt), ARTHRALGIA (right wrist hurt) and LYMPHADENOPATHY (swollen lymph node right side of my Armpit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 99.3 (abnormal) 99.3.         Concomitant medication was not provided.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus
Clinical narrative: swollen arm; itchy arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm) and PRURITUS (itchy arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Jan-2021, the patient experienced PERIPHERAL SWELLING (swollen arm) and PRURITUS (itchy arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 01-Feb-2021, PERIPHERAL SWELLING (swollen arm) and PRURITUS (itchy arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-076361 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: No new information added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076361:Crossed linked, 2nd dose case
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: diarrhea; Constant vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and VOMITING (Constant vomiting) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder (overactive immune system) and Depression.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced DIARRHOEA (diarrhea) and VOMITING (Constant vomiting). At the time of the report, DIARRHOEA (diarrhea) and VOMITING (Constant vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was taking concomitant medications. No treatment information was provided
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased activity, Diarrhoea, Fatigue, Headache
Clinical narrative: Missing work; Nauseous; Headache; Chills; Extreme fatigue; Not feeling well/ felt sick; Couldn't get out of the couch; Diarrhea; Sweating at night; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well/ felt sick), DECREASED ACTIVITY (Couldn't get out of the couch), DIARRHOEA (Diarrhea), HYPERHIDROSIS (Sweating at night) and IMPAIRED WORK ABILITY (Missing work) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced MALAISE (Not feeling well/ felt sick), DECREASED ACTIVITY (Couldn't get out of the couch), DIARRHOEA (Diarrhea), HYPERHIDROSIS (Sweating at night), NAUSEA (Nauseous), HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Extreme fatigue). On an unknown date, the patient experienced IMPAIRED WORK ABILITY (Missing work). At the time of the report, MALAISE (Not feeling well/ felt sick), DECREASED ACTIVITY (Couldn't get out of the couch), DIARRHOEA (Diarrhea), HYPERHIDROSIS (Sweating at night), IMPAIRED WORK ABILITY (Missing work), NAUSEA (Nauseous), HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Extreme fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-076982 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Impaired work ability, Malaise, Nausea
Clinical narrative: Missing work; Nauseous; Headache; Chills; Extreme fatigue; Not feeling well/ felt sick; Couldn't get out of the couch; Diarrhea; Sweating at night; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well/ felt sick), DECREASED ACTIVITY (Couldn't get out of the couch), DIARRHOEA (Diarrhea), HYPERHIDROSIS (Sweating at night) and IMPAIRED WORK ABILITY (Missing work) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced MALAISE (Not feeling well/ felt sick), DECREASED ACTIVITY (Couldn't get out of the couch), DIARRHOEA (Diarrhea), HYPERHIDROSIS (Sweating at night), NAUSEA (Nauseous), HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Extreme fatigue). On an unknown date, the patient experienced IMPAIRED WORK ABILITY (Missing work). At the time of the report, MALAISE (Not feeling well/ felt sick), DECREASED ACTIVITY (Couldn't get out of the couch), DIARRHOEA (Diarrhea), HYPERHIDROSIS (Sweating at night), IMPAIRED WORK ABILITY (Missing work), NAUSEA (Nauseous), HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Extreme fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-076982 (Patient Link).
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Lethargy, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Flu-like symptoms; Sniffles; Lethargic; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), RHINORRHOEA (Sniffles) and LETHARGY (Lethargic) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Blood pressure high.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), RHINORRHOEA (Sniffles) and LETHARGY (Lethargic). On 01-Apr-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms), RHINORRHOEA (Sniffles) and LETHARGY (Lethargic) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included (unspecified) medications for for asthma and high blood pressure.  Reportedly, the symptoms were so bad and it took 4-5 days for them to go away.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Vaccination adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported by the reporter. No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Somnolence
Clinical narrative: Feeling extremely weak; Can't stay awake; Fatigued,extramly tired; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Feeling extremely weak), SOMNOLENCE (Can't stay awake) and FATIGUE (Fatigued,extramly tired) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced ASTHENIA (Feeling extremely weak), SOMNOLENCE (Can't stay awake) and FATIGUE (Fatigued,extramly tired). At the time of the report, ASTHENIA (Feeling extremely weak), SOMNOLENCE (Can't stay awake) and FATIGUE (Fatigued,extramly tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reportedly, the patient was on concomitant medications but denied providing further information stating she did not think those medications had anything to do with the symptoms.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Migraine, Movement disorder
Clinical narrative: Extreme shaking; Dizziness/ light headedness; Body hurt; In bed for 48 hours; Migraine; Headache; Chills/ chattering of teeth; Intense body aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Extreme shaking), DIZZINESS (Dizziness/ light headedness), PAIN (Body hurt), MOVEMENT DISORDER (In bed for 48 hours) and MIGRAINE (Migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 011AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included HYDROXYCHLOROQUINE, METFORMIN, ASPIRIN [ACETYLSALICYLIC ACID] and DEXLANSOPRAZOLE (DEXILANT) for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced NAUSEA (Nausea). On 11-Apr-2021, the patient experienced TREMOR (Extreme shaking), DIZZINESS (Dizziness/ light headedness), PAIN (Body hurt), MOVEMENT DISORDER (In bed for 48 hours), MIGRAINE (Migraine), HEADACHE (Headache), CHILLS (Chills/ chattering of teeth) and MYALGIA (Intense body aches). At the time of the report, TREMOR (Extreme shaking), DIZZINESS (Dizziness/ light headedness), PAIN (Body hurt), MOVEMENT DISORDER (In bed for 48 hours), MIGRAINE (Migraine), NAUSEA (Nausea), HEADACHE (Headache), CHILLS (Chills/ chattering of teeth) and MYALGIA (Intense body aches) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2021-076281 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow-up received on 06-MAY-2021 included no new information.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain, Tremor
Clinical narrative: Extreme shaking; Dizziness/ light headedness; Body hurt; In bed for 48 hours; Migraine; Headache; Chills/ chattering of teeth; Intense body aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Extreme shaking), DIZZINESS (Dizziness/ light headedness), PAIN (Body hurt), MOVEMENT DISORDER (In bed for 48 hours) and MIGRAINE (Migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 011AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included HYDROXYCHLOROQUINE, METFORMIN, ASPIRIN [ACETYLSALICYLIC ACID] and DEXLANSOPRAZOLE (DEXILANT) for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced NAUSEA (Nausea). On 11-Apr-2021, the patient experienced TREMOR (Extreme shaking), DIZZINESS (Dizziness/ light headedness), PAIN (Body hurt), MOVEMENT DISORDER (In bed for 48 hours), MIGRAINE (Migraine), HEADACHE (Headache), CHILLS (Chills/ chattering of teeth) and MYALGIA (Intense body aches). At the time of the report, TREMOR (Extreme shaking), DIZZINESS (Dizziness/ light headedness), PAIN (Body hurt), MOVEMENT DISORDER (In bed for 48 hours), MIGRAINE (Migraine), NAUSEA (Nausea), HEADACHE (Headache), CHILLS (Chills/ chattering of teeth) and MYALGIA (Intense body aches) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2021-076281 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow-up received on 06-MAY-2021 included no new information.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Pain in extremity, Pyrexia, Vaccination site rash, Vaccination site warmth
Clinical narrative: Arm has been sore since she received the vaccine; Fever; rash and heat at the injection site; Rash and heat at the injection site; period heavier than normal; Covid arm; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (period heavier than normal), PAIN IN EXTREMITY (Arm has been sore since she received the vaccine), VACCINATION SITE WARMTH (Rash and heat at the injection site), PAIN IN EXTREMITY (Covid arm) and PYREXIA (Fever) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021b21a and 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included MELOXICAM for Arthritis.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced PAIN IN EXTREMITY (Covid arm). On 14-Apr-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (period heavier than normal), VACCINATION SITE WARMTH (Rash and heat at the injection site) and VACCINATION SITE RASH (rash and heat at the injection site). On 28-Apr-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm has been sore since she received the vaccine). On 16-Apr-2021, PAIN IN EXTREMITY (Covid arm) had resolved. On 30-Apr-2021, PYREXIA (Fever) had resolved. At the time of the report, HEAVY MENSTRUAL BLEEDING (period heavier than normal), PAIN IN EXTREMITY (Arm has been sore since she received the vaccine), VACCINATION SITE WARMTH (Rash and heat at the injection site) and VACCINATION SITE RASH (rash and heat at the injection site) outcome was unknown.            No treatment medication was reported.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: The follow up was received: patient demographic details was added
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Asthenia, COVID-19, Cough, Headache
Clinical narrative: lost sense of smell; oxygen dropped; more than 36 days between first and second dose; tested positive for covid again; weakness; cough; tested positive for covid; headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), COVID-19 (tested positive for covid), COVID-19 (tested positive for covid again), ASTHENIA (weakness) and ANOSMIA (lost sense of smell) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced COUGH (cough), COVID-19 (tested positive for covid), ASTHENIA (weakness) and HEADACHE (headache). On 11-Apr-2021, the patient experienced COVID-19 (tested positive for covid again). On an unknown date, the patient experienced ANOSMIA (lost sense of smell), OXYGEN CONSUMPTION DECREASED (oxygen dropped) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than 36 days between first and second dose). The patient was treated with VITAMINS NOS at an unspecified dose and frequency. At the time of the report, COUGH (cough), COVID-19 (tested positive for covid), COVID-19 (tested positive for covid again), ASTHENIA (weakness), ANOSMIA (lost sense of smell), OXYGEN CONSUMPTION DECREASED (oxygen dropped), HEADACHE (headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than 36 days between first and second dose) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Oxygen saturation: 94 (abnormal) dropped to 94% and 96 (abnormal) but then improved around 96%. On 23-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive. On 11-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products included high blood pressure medication and blood sugar medication.